XML 23 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Interim Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Cash flows (used in) provided by operating activities:          
Net income (loss) $ 745 $ 520 $ (11,154) $ 4,591  
Adjustments to reconcile net (loss) income to net cash used in operating activities:          
Depreciation and amortization     9,364 4,540  
Amortization of deferred charges     234 57  
Share of loss (income) from joint ventures (38) (1,306) 175 (4,885)  
Bad debt expense     (19)    
Interest expense 620 299 1,959 1,273  
Interest income (50) (101) (99) (577)  
Interest paid on long-term debt     (2,926) (1,318)  
Unrealized foreign exchange gain/loss     19    
Gain on settlement agreement       (4,681)  
Loss on disposal of assets     40 6  
Non-cash lease expense     (376) (935)  
Interest paid on finance lease   (1) (1) (3)  
Share-based compensation     5,705 1,329  
Deferred income taxes     (3,196) (321)  
Changes in non-cash working capital items     (20,831) 4,938  
Net cash (used in) provided by operating activities     (21,106) 4,014  
Cash flows used in investing activities:          
Purchases of property, plant and equipment     (15,131) (1,076)  
Advances to joint ventures     (15) (133)  
Acquisitions, net     (25,944) (11,713)  
Investment in minority interests     (1,109) (1,226)  
Net cash used in investing activities     (42,199) (14,148)  
Cash flows provided by financing activities:          
Proceeds from borrowings     4,147 3,000  
Repayments on borrowings     (7,410) (4,326)  
Proceeds from issuance of common stock and warrants     135,000 46,388  
Issuance costs     (7,511) (3,819)  
Proceeds from exercise of stock options     199 251  
Proceeds from exercise of warrants     18,495 11,369  
Share re-purchases     (5,000)    
Payments on capital lease obligations     (537) (51)  
Payment of note payable related to acquisition of Pure Sunfarms     (15,498)    
Net cash provided by financing activities     121,885 52,812  
Effect of exchange rate changes on cash and cash equivalents     191 (1)  
Net increase in cash and cash equivalents     58,771 42,677  
Cash and cash equivalents, beginning of period     25,679 11,989 $ 11,989
Cash and cash equivalents, end of period $ 84,450 $ 54,666 84,450 $ 54,666 $ 25,679
Supplemental disclosure of non-cash activities:          
Shares issued for acquisition     $ 41,752